GSTA4 and pachyonychia congenita: To further elucidate the prognostic relevance of GSTA4 in PC, survival analyses were performed across multiple cohorts of patients with PC, including disease-free survival, disease-specific survival, overall survival, progression-free survival, and relapse-free survival.